Cyclobenzaprine Lawsuit

A Brief Guide to Filing a Cyclobenzaprine Lawsuit

What is Cyclobenzaprine?

Cyclobenzaprine, which is sold as Flexeril, Fexmid and Amrix, is a muscle relaxant used to relieve pain and discomfort caused by sprains, strains and other muscle injuries. Cyclobenzaprine is only available via prescription and comes in either tablet or extended-release capsule form.

Cyclobenzaprine Side Effects:

Prescribed to patients who are experiencing skeletal muscle spasms and related pain, a Cyclobenzaprine dosage can be taken without concern over side effects. The riskiest possible Cyclobenzaprine side effects will be incurred by patients who overdose on the drug and this of course is unlikely to serve as legitimate grounds for a Cyclobenzaprine lawsuit.

In clinical tests concerning Cyclobenzaprine side effects, most of the results confirmed that the bulk of patients do not experience adverse reactions. Whether the Cyclobenzaprine dosage taken was in a 5 or 10 mg tablet, many patients reported only drowsiness or dry mouth. Because of these relative marginal effects, there has been no significant Cyclobenzaprine lawsuit concerning damage since the drug’s introduction. Therefore, unless further studies indicate that previously unreported Cyclobenzaprine side effects may exist, you are unlikely to achieve remuneration for any condition or damage imposed.

It is possible to take an excess of a prescribed Cyclobenzaprine dosage and experience an overdose. There are; however, very few reported cases of Cyclobenzaprine overdoses. No notable Cyclobenzaprine lawsuit has been filed over an overdose. One 2006 medical report published in the Journal of Occupational Medicine and Toxicology reported on a man who had deliberately exceeded his Cyclobenzaprine dosage in an attempt to commit suicide. His Cyclobenzaprine side effects included a muscle breakdown known as rhabdomyolysis. However, to date there is no record of patients who filed a Cyclobenzaprine lawsuit over effects that proceeded from physician-supervised intake.

There are some rare but serious Cyclobenzaprine side effects such as heart attacks and chest pain. Any patient who observes such a response to a Cyclobenzaprine dosage must seek immediate medical attention. However, the information provided with the medication warns of this risk and therefore does not offer victims the opportunity to file a Cyclobenzaprine lawsuit.

Cyclobenzaprine FDA Warnings:

Cyclobenzaprine, according to FDA studies, is closely related to tricyclic antidepressants (i.e. amitriptyline and imipramine). In short term evaluations for indications other than muscle spasms, some more serious central nervous system reactions were observed with tricyclic antidepressants.

Cyclobenzaprine Lawsuits:

Given the lack of risk currently associated with taking a Cyclobenzaprine dosage, there is little reason to expect prominent litigation to be associated with the drug. In recent years, attention has been paid to the drug's properties in helping relieve fibromyalgia pain. Patients who are prescribed the drug off-label for this purpose should follow their doctor's instructions to avoid potential Cyclobenzaprine side effects. No serious medical research has been conducted concerning the potential risks of taking a Cyclobenzaprine dosage for fibromyalgia.

There are a few limited conditions under which you may consider a Cyclobenzaprine lawsuit. Patients who experience Cyclobenzaprine side effects not warned against in prescription information may be entitled to compensation on the grounds that they were not sufficiently warned of such risks. Patients who take--and subsequently suffer from--incorrectly manufactured medication may also file a Cyclobenzaprine lawsuit for negligence. And lastly, patients whose physician's fail to take adequate steps to control a serious reaction to an adverse reaction may be sued for malpractice. However, with no public record of such cases being successful, it is unclear what the chance of success for such a Cyclobenzaprine lawsuit would be.

Sources:

1. United States National Library of Medicine "Cyclobenzaprine" retrieved from:

http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000699/

2. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=

Search.SearchAction&SearchTerm=cyclobenzaprine&SearchType=BasicSearch

3. http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/017821s045lbl.pdf